yttrium has been researched along with Bile Duct Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aliseda, D; Benito, A; Bilbao, JI; Ciria, R; Hidalgo, F; Iñarrairaegui, M; Lopez-Olaondo, L; Martí-Cruchaga, P; Pardo, F; Rodríguez-Fraile, M; Rotellar, F; Sangro, B; Zozaya, G | 1 |
| Gastaca Mateo, M; Martínez de la Cuesta, A; Prieto Calvo, M; Rodríguez-Fraile, M; Villalabeitia Ateca, I | 1 |
| Balius, AM; Bourgeois, AC; Chang, TT; Pasciak, AS | 1 |
3 other study(ies) available for yttrium and Bile Duct Neoplasms
| Article | Year |
|---|---|
Pure laparoscopic major liver resection after yttrium
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Feasibility Studies; Hepatectomy; Humans; Laparoscopy; Length of Stay; Liver Neoplasms; Postoperative Complications; Retrospective Studies; Yttrium | 2022 |
Radioembolization with yttrium as neoadjuvant therapy in initially unresectable intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; Neoadjuvant Therapy; Yttrium | 2023 |
Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium | 2013 |